Studies suggest that these newer potassium binders allow patients to remain on RAASis in the treatment of chronic kidney disease and heart failure.[33,34] Consequences of discontinuing guideline-directed medical therapies RAASis and MRAs are both key disease-modifying agents for treating chronic kidney disease, cardiovascular disease, and diabetes mellitus.[35-37] They lead to increases in potassium concentration due to their interference with aldosterone (indirect and direct blockade), thus impairing excretion by the kidney
If your pup is still healthy, nows the time to explore coverage
A brand-new systematic review just hit the journals, and its the most comprehensive look weve seen yet at the mechanism, the MSK outcomes, and the massive safety gray areas surrounding this compound
While menstrual irregularities are not listed among the primary side effects, real-world experiences do indeed show some changes
The C-terminus has an amide group rather than a free carboxylic acid, which minimizes rapid degradation
Vitamin B12 Injection